NASDAQ:INO   Inovio Pharmaceuticals, Inc.
INO looks like it had healthy profit-taking before earnings to have another go, earnings may be looking more forward with new COVID vaccine pipelines.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.